Merck 1Q Revenues: $11.7 billion (+1%) 1Q Earnings: $1.7 billion (+67%) Comments: Pharmaceuticals sales were up 3%, driven by Januvia, up 24% to $919 million, Victrelis sales of $111 million, Janumet, up 29% to $392 million, Gardasil, up 33% to $284 million, Zostavax, up 68% to $76 million, and Isentress, up 15% to $337 million. Remicade sales declined 31% to $519 million as a result of territories transferred to Johnson & Johnson as a result of the arbitration settlement agreement Cozaar...